Finally, our findings reveal a pattern of MIS-C-defining molecular features (IL15/IL15RA, MIP1α, TNFα, and IL1 pathways) and clinical and laboratory parameters (thrombocytopenia, eosinopenia, and reduced myocardial function). This evidence concerns the gene CCL3 and Thrombocytopenia.